canSCREEN in Malaysia

The ROSE Foundation, a collaboration between ACPCC and the University of Malaya, integrates the innovative self-sampling model, primary HPV screening and a digital population health registry developed by ACPCC using the canSCREEN platform.

With the three components of self-sampling, HPV testing and canSCREEN, ROSE delivers an integrated screening service that is acceptable to women and ensures that women do not “fall through the cracks”, with healthcare professionals able to track the progress of every woman screened, regardless of where she was screened.

After women carry out the self-sampling HPV test, their samples are sent to the ROSE Laboratory in Malaysia for HPV testing. Results of the HPV test are then communicated to the women via mobile phone allowing them to seamlessly navigate through an otherwise complex and overwhelming healthcare system.

Women in whom HPV is detected are also provided with a phone number for counselling and organising their follow-up care. Current data from the ROSE Foundation indicates that over 23,000 women have been screened under this program, across 160 community locations and clinics throughout Malaysia.

These incredible outcomes were made possible through the hard work of the Program ROSE team in Malaysia, facilitated by canSCREEN. ACPCC provides ongoing support to the ROSE Foundation and has recently assisted with the acquisition of a dedicated a new Roche Cobas 4800 system for HPV testing in the ROSE Laboratory, building in-country capacity for testing.

“A seamless screening management system is critical to ensure that women are linked to follow-up care.  The patient navigation platform must also be flexible enough to be accessed in the community or hospital so that patient pathways are tailored to communities and not the other way round. CanSCREEN is flexible in that it can tailor to how and where women are screened and followed-up.”  Prof Yin Ling Woo

Search our site